![](/img/cover-not-exists.png)
ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
J. J. Kastelein, H. N. Ginsberg, G. Langslet, G. K. Hovingh, R. Ceska, R. Dufour, D. Blom, F. Civeira, M. Krempf, C. Lorenzato, J. Zhao, R. Pordy, M. T. Baccara-dinet, D. A. Gipe, M. J. Geiger, M. FarYear:
2015
Language:
english
DOI:
10.1093/eurheartj/ehv370
File:
PDF, 330 KB
english, 2015